The forecast for hospital discharges for carcinoma in situ in the UK indicates a gradual decline from 2024 to 2028, starting at 5.99 thousand and decreasing to 5.5 thousand by 2028. Prior to 2024, the exact value is unavailable, but the trend suggests a continuation from preceding years. The year-on-year percentage change shows an average annual decrease, with a compound annual growth rate (CAGR) reflecting a steady decline over the five years.

Future trends to watch for include:

Advancements in early detection and screening techniques potentially reducing discharge numbers further.
Policy changes in healthcare that could impact hospital admission and discharge rates.
Innovations in treatment methods contributing to fewer hospitalizations.